Galectin Therapeutics (GALT) Tops Q1 EPS by 5c
Tweet
Share
E-mail
Get Alerts GALT Hot Sheet
Join SI Premium – FREE
Galectin Therapeutics (NASDAQ: GALT) reported Q1 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Galectin Therapeutics (GALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
- Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy
- Jefferies Downgrades BSE Limited (BSE:IN) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
